Related Experiment Video
Updated: Jun 19, 2026
Layer-by-layer Collagen Deposition in Microfluidic Devices for Microtissue Stabilization
Published on: September 29, 2015
[Smad7 inhibits collagen expression in human hepatic satellite cells in vitro]
Li-xia Tang1, Guang Yang, Jia-ju Tang
1First People's Hospital of Foshan City, Guangdong 528000, China.
Objective:
To investigate the effect of Smad7 on the expressions of collagen I and alpha-smooth muscle actin (alpha-SMA) in HSC-T6 cell line activated by transforming growth factor-beta1 (TGF-beta1).
Methods:
HSC-T6 cells stably expressing M2-flag protein were selected after co-infection of the cells with pTRE-Smad7-M2-flag and pTet-on. The optimal dose of doxycycline for inducing Smad7 was determined, and the effects of Smad7 over-expression on the expressions of collagen I and alpha-SMA in the cells activated by TGF-beta1 and on Smad2/3 phosphorylation were evaluated using Western blotting.
Results:
The optimal dose of doxycycline for inducing Smad7 expression was 2 mg/L. Smad7 over-expression induced by doxycycline decreased the expressions of collagen I and alpha-SMA in HSC-T6 cells activated by TGF-beta1, and down-regulated the level of Smad2/3 phosphorylation.
Conclusion:
Smad7 over-expression inhibits Smad2/3 phosphorylation, and decreases the expression of collagen I and alpha-SMA in HSC-T6 cells induced by TGF-beta1 to inhibit the progression of liver fibrosis.
Insights
Smad7 overexpression effectively reduces collagen I and alpha-SMA expression in liver cells stimulated by TGF-beta1. This finding suggests Smad7 as a potential therapeutic target for inhibiting liver fibrosis progression.
Area of Science:
- Cell Biology
- Molecular Biology
- Hepatology
Context:
- Liver fibrosis is a significant health concern characterized by excessive extracellular matrix deposition.
- Transforming growth factor-beta1 (TGF-beta1) is a key mediator in the activation of hepatic stellate cells (HSCs) and subsequent fibrosis.
- Smad7, an inhibitory Smad protein, plays a crucial role in TGF-beta signaling pathways.
Purpose:
- To investigate the inhibitory effect of Smad7 on collagen I and alpha-smooth muscle actin (alpha-SMA) expression in HSC-T6 cells.
- To determine the impact of Smad7 overexpression on TGF-beta1-induced HSC activation and Smad2/3 phosphorylation.
Summary:
- HSC-T6 cells were engineered for inducible Smad7 overexpression using doxycycline.
- Western blotting confirmed that Smad7 overexpression, induced by 2 mg/L doxycycline, significantly decreased collagen I and alpha-SMA levels.
- Smad7 overexpression also led to the downregulation of Smad2/3 phosphorylation in TGF-beta1-stimulated HSC-T6 cells.
Impact:
- Smad7 overexpression demonstrates a potent inhibitory effect on key fibrotic markers in hepatic stellate cells.
- These findings highlight the therapeutic potential of modulating Smad7 for the treatment of liver fibrosis.
- Targeting Smad7 may offer a novel strategy to counteract TGF-beta1-driven fibrotic processes in the liver.
